| Total (N = 305) | Probable CIs (N = 70) | No CI (N = 235) | p value | Effect size |
---|---|---|---|---|---|
Mean (SD) / N (%) | |||||
Sociodemographic | |||||
 Gender |  |  |  | .435 | 0.05 |
  Female | 130 (42.6%) | 27 (38.6%) | 103 (43.8%) |  |  |
  Male | 175 (57.4%) | 43 (61.4%) | 132 (56.2%) |  |  |
 Age (years) | 53.97 (11.06) | 55.70 (10.05) | 53.45 (11.31) | .136 | 0.20 |
 Ethnicity |  |  |  | .268 | 0.12 |
  Chinese | 162 (54.5%) | 45 (64.3%) | 117 (51.5%) |  |  |
  Malay | 112 (37.7%) | 20 (28.6%) | 92 (40.5%) |  |  |
  Indian | 22 (7.4%) | 5 (7.1%) | 17 (7.5%) |  |  |
  Others | 1 (0.3%) | 0 (0.0%) | 1 (0.4%) |  |  |
 Highest Education |  |  |  | .160 | 0.08 |
  Secondary or lower | 252 (84.0%) | 60 (89.6%) | 192 (82.4%) |  |  |
  Post-secondary or higher | 48 (16.0%) | 7 (10.4%) | 41 (17.6%) |  |  |
 Relationship status |  |  |  | .615 | 0.03 |
  In a relationship | 201 (67.2%) | 44 (64.7%) | 157 (68.0%) |  |  |
  Not in a relationship | 98 (32.8%) | 24 (35.3%) | 74 (32.0%) |  |  |
 Working status |  |  |  | .798 | 0.02 |
  Working | 108 (41.1%) | 23 (42.6%) | 85 (40.7%) |  |  |
  Not working | 155 (58.9%) | 31 (57.4%) | 124 (59.3%) |  |  |
 Household income |  |  |  | .906 | 0.01 |
  S$2000 or below | 148 (61.4%) | 36 (62.1%) | 112 (61.2%) |  |  |
  Above S$2000 | 93 (38.6%) | 22 (37.9%) | 71 (38.8%) |  |  |
Clinical | |||||
 Age at ESRD diagnosis | 45.67 (14.28) | 48.73 (14.39) | 44.79 (14.15) | .046* | 0.28 |
 Primary kidney disease diagnosis |  |  | .135 | 0.18 | |
  Diabetic nephropathy | 107 (39.2%) | 31 (51.7%) | 76 (35.7%) |  |  |
  Primary glomerulonephritis | 65 (23.8%) | 10 (16.7%) | 55 (25.8%) |  |  |
  Hypertension | 20 (7.3%) | 2 (3.3%) | 18 (8.5%) |  |  |
  IgA nephropathy | 23 (8.4%) | 7 (11.7%) | 16 (7.5%) |  |  |
  Polycystic kidney disease | 8 (2.9%) | 2 (3.3%) | 6 (2.8%) |  |  |
  Others/uncertain aetiology | 50 (18.3%) | 8 (13.3%) | 42 (19.7%) |  |  |
 Time on HD (months) | 55.73 (57.70) | 38.93 (44.08) | 60.79 (60.39) | .001** | 0.38 |
  0–6 months | 67 (22.6%) | 22 (32.4%) | 45 (19.7%) | .008** | 0.18 |
  7–24 months | 51 (17.2%) | 16 (23.5%) | 35 (15.3%) |  |  |
  Beyond 24 months | 179 (60.3%) | 30 (44.1%) | 149 (65.1%) |  |  |
 Presence of cerebrovascular disease |  |  | .182 | 0.08 | |
  No | 265 (90.4%) | 56 (86.2%) | 209 (91.7%) |  |  |
  Yes | 28 (9.6%) | 9 (13.8%) | 19 (8.3%) |  |  |
 Presence of hypertension |  |  |  | .027* | 0.13 |
  No | 24 (8.2%) | 1 (1.5%) | 23 (10.1%) |  |  |
  Yes | 269 (91.8%) | 64 (98.5%) | 205 (89.9%) |  |  |
 Presence of diabetes |  |  |  | .040* | 0.12 |
  No | 154 (52.7%) | 27 (41.5%) | 127 (55.9%) |  |  |
  Yes | 138 (47.3%) | 38 (58.5%) | 100 (44.1%) |  |  |
 CCI | 4.96 (2.15) | 5.34 (1.92) | 4.85 (2.20) | .107 | 0.23 |
 Kt/V | 1.47 (0.48) | 1.39 (0.29) | 1.49 (0.52) | .124 | 0.22 |
 Serum phosphorus | 5.31 (3.44) | 4.89 (1.35) | 5.42 (3.82) | .274 | 0.16 |
 Serum potassium | 4.74 (0.69) | 4.63 (0.77) | 4.77 (0.77) | .151 | 0.21 |
 IDWGr | 3.85 (1.08) | 3.80 (1.09) | 3.86 (1.07) | .697 | 0.06 |